Frequent β-catenin aberration in human hepatocellular carcinoma

Hepatology Research

Volumn 20, Issue 1, 2001, Pages 39-51

  Fujie, Hajime ^a   Moriya, Kyoji ^a   Shintani, Yoshizumi ^a   Tsutsumi, Takeya ^a   Takayama, Tadatoshi ^b   Makuuchi, Masatoshi ^b   Kimura, Satoshi ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hepatis C; Hepatocarcinogenesis; Oncogene; Western blotting

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA;

ADVANCED CANCER; AGED; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; EXON; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0035067956     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00116-9     Document Type: Article

References (52)

1. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma
2. Hepatitis virus-related hepatocarcinogenesis
3. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
4. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
5. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
6. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes
7. A versatile transcriptional effector of Wingless signaling
8. Functional interaction of β-catenin with the transcription factor LEF-1
9. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos
10. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- Colon carcinoma
11. Induction of a β-catenin-LEF-1 complex by wnt-1 and transforming mutants of β-catenin
12. β-catenin as oncogene: The smoking gun
13. Identification of c-MYC as a target of the APC pathway
14. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
15. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
16. Association of the APC gene product with β-catenin
17. Association of APC tumor suppressor protein with catenins
18. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
19. Axin, an inhibitor of the Wnt signalling pathway, interacts with β-catenin, GSK-3β and APC reduces the β-catenin level
20. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
21. β-catenin is a target for the ubiquitin-proteasome pathway
22. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
23. Stabilization of β-catenin by genetic defects in melanoma cell lines
24. Deletion of an amino-terminal sequence stabilizes β-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein
25. Relationship between heterozygosity of tumor suppressor genes and histological differentiation in hepatocellular carcinomas
26. Sporadic medulloblastomas contain oncogenic β-catenin mutations
27. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
28. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
29. Catenin mutation in carcinoma of the uterine endometrium
30. Catenin mutations in human prostate cancer
31. A common human skin tumour is caused by activating mutations in β-catenin
32. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
33. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocelluar carcinomas
34. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity
35. Classification of chronic hepatitis: Diagnosis, grading and staging
36. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification
37. Early hepatocellular carcinoma as an entity with a high rate of surgical cure
38. Persistent viremia after recovery from self-limited acute hepatitis B
39. Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors
40. APC mutations in sporadic medulloblastomas
41. Catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
42. Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
43. Catenin mutations in cell lines established from human colorectal cancers
44. Frequent β-catenin abnormalities in bone and soft-tissue tumors
45. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
46. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
47. Cytoplasmic β-catenin in esophageal cancers
48. Genomic organization of the human β-catenin gene (CTNNB1)
49. Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration
50. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma
51. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma